The notch ligand JAGGED1 as a target for anti-tumor therapy - Test2 - elhamkhani - TriplyDB

The notch ligand JAGGED1 as a target for anti-tumor therapy

The notch ligand JAGGED1 as a target for anti-tumor therapy

http://www.wikidata.org/entity/Q21129294

about

Targeting Notch to overcome radiation resistance Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis Jagged1 (JAG1): Structure, expression, and disease associations NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.Inflammatory breast cancer: a model for investigating cluster-based dissemination.EMT and MET: necessary or permissive for metastasis?Jagged-Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype.Blockade of specific NOTCH ligands: a new promising approach in cancer therapy Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via "differentiation-based nano-therapy".Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision.Ethanol inhibits γ-secretase proteolytic activity in vascular smooth muscle cells.Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi)Notch Signaling and the Skeleton.Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype.Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib.Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans.Clinical implications of APEX1 and Jagged1 as chemoresistance factors in biliary tract cancer A three-molecule score based on Notch pathway predicts poor prognosis in non-metastasis clear cell renal cell carcinoma Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway.Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer.1810011o10 Rik Inhibits the Antitumor Effect of Intratumoral CD8+ T Cells through Suppression of Notch2 Pathway in a Murine Hepatocellular Carcinoma Model.Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation Prognostic significance of Notch ligands in patients with non-small cell lung cancer BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling.Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling.Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy.Targeting bromodomain and extraterminal proteins in breast cancer.Osteopontin-integrin engagement induces HIF-1α-TCF12-mediated endothelial-mesenchymal transition to exacerbate colorectal cancer.Expression of miR-634 in gastric carcinoma and its effects on proliferation, migration, and invasion of gastric cancer cells.Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer.New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity.Jagged-1 induced molecular alterations in HPV associated invasive squamous cell and adenocarcinoma of the human uterine cervix.The Notch Pathway in Breast Cancer Progression JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells

P2860

Q26771701-9FF6D20B-DD99-450E-8141-A1053A5542CD Q26799987-5C13CBB4-2BE0-4ECA-B0E1-C6FA5BFA3226 Q28606584-643143F9-D537-4C82-908D-03412F177FDC Q30276974-B5795B8B-19D7-4373-9DBA-527280F604DD Q33767606-B681ED2C-1169-428D-B690-B1995E09F7FE Q33869775-B1EADA00-9D56-44C0-BCCF-1AEBD08E8F2A Q35062669-8206C5A3-E721-4831-83A8-23AA0E1A1BCC Q35125234-5FD98E92-9B07-4863-98FD-D4315CF289C1 Q35551810-09411DF5-1AD1-4B71-ACB8-8104366629B6 Q35895576-FF4A5E93-95F7-41E6-9F21-372101B911F7 Q36219884-A6F40C44-7DF7-4886-AE4E-CCF1916437C9 Q36479429-8FE1A599-9675-48F5-B1D5-A2FCBA5AA7C3 Q36960089-EDF11D48-DA1D-4467-BE6E-C2E1A260DD20 Q36966739-E1B8D711-F352-4293-B8F9-3F032EC09FF0 Q37205970-A4CAECE0-1013-4B9E-8A35-5C86B72F7ECE Q37525776-0FC687BE-0F3F-4243-839E-50CE76DE2E26 Q37585313-F6DF8133-F097-44FC-9AC4-5BAB921E065D Q37708831-5823AE22-8E41-45A2-AC9E-6958B8D2407D Q38719547-0B813FCA-342C-4712-A155-299478961670 Q39423655-750C4385-75A1-40A7-8963-C84C5D1F7E42 Q40262828-FC4B94AE-64BA-46EA-B974-64C2264A556E Q41472543-FF568D90-A76B-40AF-8DAA-302124886B6E Q41824016-75E36976-1124-45A2-A9B1-000E5336A359 Q43238483-168E8265-1C01-416E-B4D5-0933512DA3D0 Q46450905-59E1155D-DC12-496A-B6D2-CD264698E226 Q47162554-D9E093DF-5230-4373-842C-B1B470FF434E Q47302520-80FDD93D-9C5C-47F4-9B21-6FC2CB07C267 Q47385983-1DBE4000-0513-4EA2-9E7C-8C948B70DF75 Q49631372-431A1AC9-0A00-4B20-945A-97C26814AA23 Q49718123-39C6F4EC-A05F-422F-861D-E3564A214B72 Q49789755-C3CF7C36-0DA6-45F0-A2CA-C173B7EC1ABB Q52581757-2B3CDE32-3246-4BFB-A624-24B82D1DAB1A Q53078069-C82B2352-027C-419B-BAFD-36A470BBE176 Q55384977-74A0B250-E0B6-46A8-9718-9EDAC2ECD881 Q57109777-D19411FA-5C7B-4C63-9A19-393FFB47F3BE Q58718804-6478E6FD-19FE-406B-99F8-470A447EA503

P2860

The notch ligand JAGGED1 as a target for anti-tumor therapy

http://www.wikidata.org/entity/Q21129294

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The notch ligand JAGGED1 as a target for anti-tumor therapy

@ast

The notch ligand JAGGED1 as a target for anti-tumor therapy

@en

The notch ligand JAGGED1 as a target for anti-tumor therapy

@en-gb

The notch ligand JAGGED1 as a target for anti-tumor therapy

@nl

type

label

The notch ligand JAGGED1 as a target for anti-tumor therapy

@ast

The notch ligand JAGGED1 as a target for anti-tumor therapy

@en

The notch ligand JAGGED1 as a target for anti-tumor therapy

@en-gb

The notch ligand JAGGED1 as a target for anti-tumor therapy

@nl

prefLabel

The notch ligand JAGGED1 as a target for anti-tumor therapy

@ast

The notch ligand JAGGED1 as a target for anti-tumor therapy

@en

The notch ligand JAGGED1 as a target for anti-tumor therapy

@en-gb

The notch ligand JAGGED1 as a target for anti-tumor therapy

@nl

P1433

Q21129294-9A9FB627-DCDA-47E8-8C7A-6FEB6A6E14CC

P1476

Q21129294-79B5ED2B-0A37-4017-8B3D-C881E10371FA

P2093

Q21129294-0970A890-D7DA-4B7A-83E7-112E45F0A987

P2860

Q21129294-0036CECA-EE37-4594-B490-BE364455D6CD

Q21129294-003CB748-57D9-4CF5-A4D8-1309F9C2F80C

Q21129294-00FB912D-C474-4668-B7FB-46018C621DC8

Q21129294-01F72598-F20D-402A-990B-D912F4C92125

Q21129294-035FED84-C10F-4324-A878-A88C9A8E1D9C

Q21129294-0C700F09-4EF1-4C14-A4B5-1AEC7DC4A507

Q21129294-0D164692-DC44-4144-A81C-A912CFFA169A

Q21129294-0D3DD120-6B98-4E34-BF44-8540A43946E4

Q21129294-0E243E94-ED95-4119-8C7C-C1383AD25A8F

Q21129294-102FADD3-B3EC-4352-B88F-1CBC5C71431F

P304

Q21129294-F35A71A5-4ADC-4C9F-A5AC-EDB1D75B59A0

P31

Q21129294-7C8B805C-CA5E-487E-9101-821EDC1E3FB5

P3181

Q21129294-6CD299A2-FF37-41C3-B015-83C0BD461AA4

P356

Q21129294-625740C5-AA44-4E95-9C9F-15DC64AD6954

P407

Q21129294-6DEA3881-2E03-4191-AE0C-032BF441EDA0

P478

Q21129294-0F36B3CA-52AE-467A-B6FF-56EFF7CBBF4B

P50

Q21129294-02222EC0-AE8A-4B55-81D6-CC9D14DE4932

Q21129294-73C6F5E3-3882-476F-90DA-65A940B5093C

Q21129294-BB421231-F9E3-4D23-A90A-810644196673

P577

Q21129294-1122C99C-46D2-4226-B951-E28A06D70E0D

P5875

Q21129294-D0E22603-5C88-43CB-851E-B911205023CC

P698

Q21129294-F5E750D7-5C02-4528-83BA-5A45C9B2B3FE

P932

Q21129294-F7A085EB-5AE0-4626-AF8B-69A94338C228

P3181

P356

FONC.2014.00254

P1433

Frontiers in Oncology

P1476

The notch ligand JAGGED1 as a target for anti-tumor therapy

@en

P2093

Massimo Masiero

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin.

The CD46-Jagged1 interaction is critical for human TH1 immunity

TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms

Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation

Modes of resistance to anti-angiogenic therapy

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?

NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

P304

254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1949650

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FONC.2014.00254

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Alison H Banham

Adrian L Harris

P577

2014-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266947589

http://www.w3.org/2001/XMLSchema#string

P698

25309874

http://www.w3.org/2001/XMLSchema#string

P932

4174884

http://www.w3.org/2001/XMLSchema#string